inTEST (INTT) Q4 2025 earnings review
Diversification Strategy Drives Rebound Despite Semi Weakness
inTEST broke out of its mid-year slump in Q4, beating its $30-32M revenue guidance to deliver $32.8M. More importantly, the volume recovery flowed straight to the bottom line. Gross margin expanded 350 basis points sequentially to 45.4%, enabling the company to reverse three quarters of operating losses. The legacy Semiconductor segment remains depressed, but the company's diversification strategy is working: nearly 80% of Q4 revenue came from outside the Semi market. With backlog accelerating 36% YoY to $53.9M, management is projecting stable profitability into FY26.
🐂 Bull Case
Backlog grew 9.4% sequentially and 36.4% YoY to reach $53.9M. Sustained order strength ($37.5M in Q4) provides excellent visibility, with 60% of backlog scheduled to ship beyond Q1 2026.
Achieving a 45.4% gross margin while the high-margin Semi business is down 43% YoY is a massive win. It proves manufacturing efficiencies and new Alfamation products are structurally elevating profitability.
🐻 Bear Case
The legacy Semi segment continues to drag on total growth, falling to $6.9M in Q4. A meaningful recovery is not expected until the second half of 2026.
The company remains under a covenant waiver agreement with its U.S. lender through Q1 2026, requiring them to pledge cash equal to U.S. debt outstanding ($3.8M at quarter end).
⚖️ Verdict: 🟢
Bullish. The strategic pivot away from cyclical semiconductor dependence is taking root. By achieving 45% gross margins and booking $37M in orders against a weak macro backdrop, inTEST is well-positioned for operating leverage when the semiconductor market inevitably turns.
Key Themes
Industrial and Life Sciences Breakout
The diversification strategy is accelerating. Q4 Industrial revenue surged 209% YoY to $6.9M, while Life Sciences soared 228% YoY to $4.0M. These two segments combined generated nearly $11M in Q4, completely offsetting the YoY drop in Semiconductor sales and proving the company's non-semi offerings are gaining major market traction.
Semiconductor Demand Fails to Recover
Semi revenue is decelerating further, hitting a low of $6.9M (-43% YoY). While management anticipates a 'modest pick-up' in H2 2026, the ongoing weakness means inTEST must rely entirely on nascent markets to drive top-line growth in the near term.
Margin Enhancement via New Products and Efficiency
Gross margin is reversing its mid-year compression, jumping to 45.4% from 41.9% last quarter. Management explicitly credited sales of new products at Alfamation and Acculogic alongside year-long cost reduction initiatives. This indicates improved pricing power and better fixed-cost absorption.
Auto/EV Revenue Contraction Despite Order Growth
While management highlighted strong Auto/EV orders ($9.9M, up 182% YoY) driven by new model year programs, recognized revenue for the segment actually fell 50% YoY to $5.9M. This divergence between bookings and billings flags potential timing delays or extended conversion cycles that investors must monitor.
Macro Sentiment Gradually Unthawing
Management noted a 'gradual recovery in customer capital spending' taking shape. The $37.5M order intake marks the second consecutive quarter of strong bookings after a dismal first half of 2025, suggesting that the broader macro hesitation and tariff-related fears cited earlier in the year are finally subsiding.
Other KPIs
Despite a challenging year, the company generated $7.3M in cash from operations in FY25. This allowed them to aggressively deleverage, reducing total debt from $15.0M at the end of 2024 to $7.5M by the end of 2025. Cash and equivalents sit at a comfortable $18.1M.
Stable sequentially but slightly elevated due to higher sales commissions and marketing activity tied to the revenue beat. Restructuring costs remain minimal ($0.2M), indicating that the bulk of facility consolidations (like the Videology site) are largely complete.
Guidance
Stable. The $32.0M midpoint represents a slight sequential deceleration from Q4's $32.8M, but it reflects a massive 20% YoY acceleration compared to 25Q1's $26.6M. This demonstrates that the Q4 bounce was not a one-off anomaly.
Accelerating. Implies 12% YoY growth at the midpoint compared to FY25's $113.8M. Supported by the $53.9M backlog and recovering macro sentiment.
Stable. Management is guiding for full-year gross margins to hold at Q4 levels, significantly higher than FY25's 43.0% average. This signals confidence that the current favorable product mix is structural.
Key Questions
Auto/EV Order Conversion
Auto/EV orders were very strong this quarter at $9.9M, but segment revenue was down 50% YoY. How long are the lead times on these new 2027 model year program orders, and when should we expect them to translate into revenue?
Semi Segment Floor
You anticipate a 'modest pick-up' in Semiconductor demand in the second half of 2026. What specific leading indicators or customer conversations are giving you that timeline, rather than expecting a pushout into 2027?
Malaysia Facility Impact
With the Malaysia manufacturing facility expected to ramp up, how is that factoring into your 45% gross margin guidance for 2026? Is there margin drag during the initial ramp, or will it be accretive immediately?